| Authors: |
Piccione PM; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; dsm-firmenich, Route de la Plaine 125, 1283 La Plaine, Switzerland. Electronic address: patrick.piccione@dsm-firmenich.com., Lang MN; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; Roche Diagnostics GmbH, 82377 Penzberg, Germany., Amado Becker F; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Hofstetter A; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Marchal S; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Ly K; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Legras V; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Ewert A; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Kohler D; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Maurer R; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Willecke N; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Burwood R; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland., Kroll P; F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; Muvon Therapeutics AG, 8092 Zürich, Switzerland. |